MIRM vs ROK · rev $336.1M vs P/E 48, rev $8.34B
Mirum Pharmaceuticals Inc (MIRM) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
MIRM currently screens at market cap $6.22B. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the MIRM and ROK stock pages for the full models.
Not investment advice.